Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
RBD-Fc Vacc
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/17/2021
BNT162b2
Approved by FDA Experimental Vaccine Jun/22/2022
BBV152
Emergency use authorization Experimental Vaccine Mar/27/2021
S2GΔHR2 I3-01v9 SApNP
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/19/2021
SΔC-Fer
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/05/2021
RBD-SpyVLP
Potential treatment - pre-clinical evidence Experimental Vaccine Jan/22/2021
sMVA-N/S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-N
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
INO-4800
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2020
hAd5
Potential treatment - pre-clinical evidence Experimental Vaccine Jul/30/2020
W4P-RBD
Potential treatment - pre-clinical evidence Experimental Vaccine Feb/26/2021
LUNAR-COV19
Potential treatment - pre-clinical evidence Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
candidate vaccine
Potential treatment - theoretical effect Experimental Vaccine Mar/26/2020
sMVA-S/N
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
sMVA-S
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/30/2020
RBD-16GS-I53-50
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020
RBD-12GS-I53-50
Potential treatment - pre-clinical evidence Experimental Vaccine Oct/30/2020
mRBD
Potential treatment - pre-clinical evidence Experimental Vaccine Nov/23/2020